Metraipolis › archive › dc_1187ccf3f489

Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality — Europe PMC PMID:41372233

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41372233
DOI
10.1038/s41467-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-07T18:21:02.650Z
SHA-256 of the archived text
04d8085875bf5376822666e9119ebf4084c5990a647d01e5812d5a10d79c35af
Stable URL of this page
https://metraipolis.com/documento/dc_1187ccf3f489

How to cite

Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality — Europe PMC PMID:41372233 — Europe PMC (en), https://europepmc.org/article/MED/41372233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1187ccf3f489 (Metraipolis archive dc_1187ccf3f489, sha256 04d8085875bf5376822666e9119ebf4084c5990a647d01e5812d5a10d79c35af)
BibTeX
@misc{dc1187ccf3f489,
  title = {Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality — Europe PMC PMID:41372233},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41372233},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1187ccf3f489; sha256 04d8085875bf5376822666e9119ebf4084c5990a647d01e5812d5a10d79c35af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41372233. Agents can read the archived copy with the MCP tool read_document.